Investing.com -- Trinity Biotech plc (NASDAQ:TRIB)股票上涨4.4%,此前该公司宣布其下一代连续血糖监测(CGM)技术的临床试验结果积极。 这家生物技术公司报告称,其重新设计的无针血糖传感器在整个15天佩戴期间成功提供了准确的血糖读数,无需指尖采血校准。这一技术突破是Trinity CGM+平台开发中的重要里程碑,该平台旨在通过采用模块化设计和减少...
Source LinkInvesting.com -- Trinity Biotech plc (NASDAQ:TRIB)股票上涨4.4%,此前该公司宣布其下一代连续血糖监测(CGM)技术的临床试验结果积极。 这家生物技术公司报告称,其重新设计的无针血糖传感器在整个15天佩戴期间成功提供了准确的血糖读数,无需指尖采血校准。这一技术突破是Trinity CGM+平台开发中的重要里程碑,该平台旨在通过采用模块化设计和减少...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.